文献速递妇科产科

肿瘤健康专业人员卵巢癌基因检测主流化全国培训项目的开发与评估

The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.
PubMed 文献 · Gynecol Oncol · 2020-05-22

本研究由遗传健康专业人员开发培训模块,使肿瘤健康专业人员能主流化开展基因检测。185名肿瘤健康专业人员在35家澳大拉西亚医院的42场工作坊中受训。培训后肿瘤健康专业人员下的273例检测中241例(93.1%)符合国家检测指南,遗传健康专业人员下的检测数显著减少(z=45.0,p=0.008)。

要点

  • 培训后肿瘤健康专业人员下的检测93.1%符合国家指南。
  • 遗传健康专业人员下的检测数显著减少(z=45.0,p=0.008)。
  • 12个月时仅58%报告总是或几乎总是为合格患者开具BRCA检测。

核心结论

  • 肿瘤健康专业人员表现出参与主流化基因检测模式的意愿。
  • 若肿瘤服务承担协调基因检测的责任,需理解培训未解决的障碍以指导未来干预设计。

研究设计与样本

  • 由遗传健康专业人员开发培训模块,肿瘤健康专业人员在培训前和培训后12个月完成问卷。
  • 185名肿瘤健康专业人员在35家澳大拉西亚医院的42场工作坊中受训。
  • 培训后12个月对遗传健康专业人员进行调查以评估主流化实施的感知障碍。

主要发现

  • 肿瘤健康专业人员培训后下的273例检测中241例(93.1%)符合国家检测指南。
  • 遗传健康专业人员下的检测数显著减少(z=45.0,p=0.008)。
  • 肿瘤健康专业人员对主流化检测的感知障碍从基线到随访下降(t=2.39,p=0.023),尤其是感知技能、知识和态度。
  • 12个月时仅58%报告总是或几乎总是为合格患者开具BRCA检测。

临床怎么用

  • 肿瘤健康专业人员可参与主流化基因检测模式,但需识别并解决培训未覆盖的障碍。

局限性

  • 肿瘤健康专业人员的感知障碍未通过培训系统解决。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: BRCA1/2 mutation status has increasing relevance for ovarian cancer treatments, making traditional coordination of genetic testing by genetic services unsustainable. Consequently alternative models of genetic testing have been developed to improve testing at the initial diagnosis for all eligible women. METHODS: A training module to enable mainstreamed genetic testing by oncology healthcare professionals was developed by genetic health professionals. Oncology healthcare professionals completed questionnaires before and 12 months post-training to assess perceived skills, competence and barriers to their coordinating genetic testing for women with high-grade non-mucinous epithelial ovarian cancer. Genetic health professionals were surveyed 12 months post-training to assess perceived barriers to implementation of mainstreaming. RESULTS: 185 oncology healthcare professionals were trained in 42 workshops at 35 Australasian hospitals. Of the 273 tests ordered by oncology healthcare professionals post-training, 241 (93.1%) met national testing guidelines. The number of tests ordered by genetic health professionals reduced significantly (z = 45.0, p = 0.008). Oncology healthcare professionals' perceived barriers to mainstreamed testing decreased from baseline to follow-up (t = 2.39, p = 0.023), particularly perceived skills, knowledge and attitudes. However, only 58% reported either 'always' or 'nearly always' having ordered BRCA testing for eligible patients at 12 months, suggesting oncology healthcare professionals' perceived barriers were not systematically addressed through training. CONCLUSIONS: Oncology healthcare professionals have demonstrated a willingness to be involved in the provision of genetic testing in a mainstreaming model. If oncology services are to hold responsibility for coordinating genetic testing, their readiness will require understanding of barriers not addressed by training alone to inform future intervention design.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Gleeson M, Kentwell M, Meiser B, et al. The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients. Gynecol Oncol. 2020. PMID: 32451123. doi:10.1016/j.ygyno.2020.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。